Feed Preview


Microbiome & Cancer

Microbiome & Cancer diagram by Kateryna Kon, Shutterstock
Kateryna Kon, Shutterstock

The human microbiome has been implicated in altering cancer susceptibility and therapeutic responses to anti-cancer agents. Here is the latest research on the influence of the microbiome and cancer.

Top 20 most recent papers
Genome Biology

Author Correction: Interaction between the microbiome and TP53 in human lung cancer

Genome BiologyFebruary 22, 2020
K Leigh GreathouseCurtis C Harris
The Journal of Biological Chemistry

Bile Acid Sequestration Reverses Liver Injury and Prevents Progression of NASH in Western Diet-Fed Mice

The Journal of Biological ChemistryFebruary 21, 2020
Shogo TakahashiMoshe Levi

The virome of HPV-positive tonsil squamous cell carcinoma and neck metastasis

OncotargetFebruary 21, 2020
Ryan M CareyErle S Robertson
Nature Reviews. Urology

The microbiome and gynaecological cancer development, prevention and therapy

Nature Reviews. UrologyFebruary 20, 2020
Paweł ŁaniewskiMelissa M Herbst-Kralovetz
Microbial Pathogenesis

The oncogenic roles of bacterial infections in development of cancer

Microbial PathogenesisFebruary 2, 2020
Shirin EyvaziVahideh Tarhriz
Digestive Diseases and Sciences

Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation

Digestive Diseases and SciencesFebruary 3, 2020
Herbert L DuPontNetanya S Utay
International Journal of Molecular Sciences

Role of Mycoplasma Chaperone DnaK in Cellular Transformation

International Journal of Molecular SciencesFebruary 21, 2020
Francesca BenedettiDavide Zella
Pediatric Blood & Cancer

Review of nutritional status, body composition, and effects of antineoplastic drug disposition

Pediatric Blood & CancerFebruary 22, 2020
John T Wiernikowski, Melanie Brooke Bernhardt
Frontiers in Cellular and Infection Microbiology

The Oral Microbiota May Have Influence on Oral Cancer

Frontiers in Cellular and Infection MicrobiologyFebruary 5, 2020
Ling ZhangChen Ping Zhang
Advances in Experimental Medicine and Biology

The Microbiome as a Component of the Tumor Microenvironment

Advances in Experimental Medicine and BiologyFebruary 8, 2020
Tünde KovácsPéter Bai
Cancer & Metabolism

Metabolic models predict bacterial passengers in colorectal cancer

Cancer & MetabolismFebruary 15, 2020
Daniel R GarzaBas E Dutilh
Investigative and Clinical Urology

The human gastrointestinal microbiota and prostate cancer development and treatment

Investigative and Clinical UrologyFebruary 15, 2020
Sybil ShaVladimir Mouraviev
Cancer Treatment Reviews

Biomarkers for immunotherapy response in head and neck cancer

Cancer Treatment ReviewsFebruary 5, 2020
Niki GavrielatouAmanda Psyrri
Frontiers in Microbiology

Beyond Taxonomic Analysis of Microbiomes: A Functional Approach for Revisiting Microbiome Changes in Colorectal Cancer

Frontiers in MicrobiologyFebruary 11, 2020
Mohammad Hossein Norouzi-BeiramiKaveh Kavousi

See more papers from this feed

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

© 2020 Meta ULC. All rights reserved